Companies / Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc.

Nasdaq: RNACCIK 1453687FREDERICK, MDselectabio.com ↗

Financials · FY2025

Revenue$2.80M
Net income$-130.30M
Total debt$52.85M
Cash$147.61M
Diluted EPS$-5.02
Shares outstanding30.3M

Ownership

30.3M shares outstanding · as of Jul 31, 2026
30.7%Insiders
Ownership
Insiders30.67%9,280,506
10%+ / strategic4.52%1,366,989
Institutions14.76%4,464,871
Public float50.05%15,142,986

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Springer Timothy aDirector · 10% owner
28.58%8,646,285
Kalayoglu MuratFormerDirector · 10% owner
1.69%511,577
Brunn CarstenCEOPresident and CEO · Director
1.07%323,530
Davis BlaineChief Financial Officer
0.40%121,220
English EmilyFormerChief Operations Officer
0.31%94,226
Miljkovic MilosChief Medical Officer
0.19%58,820
Barabe Timothy CDirector
0.19%56,966
Singer MichaelDirector
0.16%49,578
Zenner Patrick JDirector
0.04%12,974
DeSilva Nishan MFormerDirector
0.04%11,366

Institutional holders 71

View all →
HolderValue% of shares
Fmr LLC$9.86M4.52%
BlackRock, Inc.$8.54M2.71%
Vanguard Group Inc$3.90M1.79%
State Street Corporation$2.60M0.82%
683 Capital Management, LLC$2.02M0.93%
Erste Asset Management GmbH$1.96M0.90%
Millennium Management LLC$1.75M0.94%
Geode Capital Management, LLC$1.62M0.87%
Privium Fund Management B.V.$1.58M0.50%
Marshall Wace, LLP$1.54M0.83%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 6, 2026Brunn Carsten
CEO
SellCommon Stock$162.1K-24K
-6.84%
323,530
1.07% of shares
medium
Jan 6, 2026Davis Blaine
Executive
SellCommon Stock$72.2K-11K
-8.04%
121,220
0.40% of shares
low
Dec 30, 2025English Emily
Executive
ExerciseCommon Stock$24.8K+8K
+11.96%
70,226
0.23% of shares
low
Jan 6, 2026Miljkovic Milos
Executive
SellCommon Stock$24.4K-4K
-5.73%
58,820
0.19% of shares
low
Jan 2, 2026Davis Blaine
Executive
GrantCommon Stock$0+37K
+39.02%
131,811
0.44% of shares
low
Jan 2, 2026Malik Kemal
Director
GrantCommon Stock$0+3K
+30.47%
11,133
0.04% of shares
low
Jan 2, 2026Brunn Carsten
CEO
GrantCommon Stock$0+143K
+70.16%
347,296
1.15% of shares
low
Jan 2, 2026DeSilva Nishan M
Director
GrantCommon Stock$0+3K
+29.66%
11,366
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Fmr LLCPassive13G/A—1,366,989—
Squarepoint Ops LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RNACCommon StockEquity816212302BBG001J19Q25